APA (7th ed.) Citation

Betts, J. C., Mayer, R. J., Tal ‐ Singer, R., Warnock, L., Clayton, C., Bates, S., . . . Singh, D. (2015). Gene expression changes caused by the p38 MAPK inhibitor dilmapimod in COPD patients: Analysis of blood and sputum samples from a randomized, placebo-controlled clinical trial. Pharmacology Research & Perspectives, 3(1), n/a. https://doi.org/10.1002/prp2.94

Chicago Style (17th ed.) Citation

Betts, Joanna C., Ruth J. Mayer, Ruth Tal ‐ Singer, Linda Warnock, Chris Clayton, Stewart Bates, Bryan E. Hoffman, Christopher Larminie, and Dave Singh. "Gene Expression Changes Caused by the P38 MAPK Inhibitor Dilmapimod in COPD Patients: Analysis of Blood and Sputum Samples from a Randomized, Placebo-controlled Clinical Trial." Pharmacology Research & Perspectives 3, no. 1 (2015): n/a. https://doi.org/10.1002/prp2.94.

MLA (9th ed.) Citation

Betts, Joanna C., et al. "Gene Expression Changes Caused by the P38 MAPK Inhibitor Dilmapimod in COPD Patients: Analysis of Blood and Sputum Samples from a Randomized, Placebo-controlled Clinical Trial." Pharmacology Research & Perspectives, vol. 3, no. 1, 2015, p. n/a, https://doi.org/10.1002/prp2.94.